Clinical Trial Update: Ciprofibrate and Pre-diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update on Ciprofibrate for pre-diabetes-related conditions; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Dysfunction
• Impaired Glucose Metabolism
• Myocardial Insulin Sensitivity

Drugs mentioned

• Ciprofibrate (ciprofibrate)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Myocardial Insulin Sensitivity, Impaired Glucose Metabolism | Phase 3 | Status: COMPLETED